A Randomized, Double-blind, Placebo-controlled, Dose-escalating, Single-dose, Oral Phase I Clinical Study of the Safety, Tolerability, and Pharmacokinetics of Flunotinib Maleate Tablets in Healthy Adult Subjects in China
Latest Information Update: 05 May 2024
At a glance
- Drugs Flonoltinib maleate (Primary)
- Indications COVID 2019 infections; Haemophagocytic lymphohistiocytosis; Myelofibrosis; Myeloproliferative disorders
- Focus Pharmacokinetics
- Sponsors Chengdu Zenitar Biomedical Technology
- 05 May 2024 New trial record